0001761918 2025-01-01 2025-12-31 DEF 14A false 0001761918 Erasca, Inc. true <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Equity Award Grant Practices </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have had no program, plan or practice pertaining to the timing of stock option grants to NEOs coinciding with the release of material <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-public</div> information. Annual grants of stock options to employees are typically approved by the Compensation Committee or our Chief Executive Officer pursuant to a delegation of authority from the Compensation Committee in the first quarter of each year as part of our annual compensation cycle. Our Board or Compensation Committee may also approve grants at other times as they deem appropriate. The timing of any equity grants to newly-hired employees, or in connection with promotions or other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-routine</div> grants, is generally tied to the event giving rise to the award, although <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-executive</div> new hire stock option awards are generally approved at the beginning of the calendar month following the individual’s commencement of employment. For all stock option awards, the exercise price is no less than the closing price of our common stock on the date of the grant (or if the grant date is not a trading day, then on the immediately preceding trading day). During 2025, we did not grant stock options, stock appreciation rights, or similar option-like instruments to our NEOs during the four business days prior to or the one business day following the filing of our periodic reports or the filing or furnishing of a Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">10-K,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">10-Q,</div> or Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">8-K</div> that discloses material nonpublic information. </div> We have had no program, plan or practice pertaining to the timing of stock option grants to NEOs coinciding with the release of material <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-public</div> information. Annual grants of stock options to employees are typically approved by the Compensation Committee or our Chief Executive Officer pursuant to a delegation of authority from the Compensation Committee in the first quarter of each year as part of our annual compensation cycle. false false